{"id":1991,"date":"2020-01-21T11:30:21","date_gmt":"2020-01-21T10:30:21","guid":{"rendered":"https:\/\/www.arbios.org\/?p=1991"},"modified":"2020-01-21T11:30:21","modified_gmt":"2020-01-21T10:30:21","slug":"aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office","status":"publish","type":"post","link":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/","title":{"rendered":"APTYS PHARMACEUTICALS, a laboratory specialized in galenical formulation, announces  that it has completed a \u20ac 2.1 million fundraiser led by NDLS Conseil from the Meeschaert family office."},"content":{"rendered":"<p>Founded in 2002 by Fran\u00e7ois Boutignon following the signing of agreements with the Universit\u00e9 d\u2019Auvergne to obtain exploitation rights for technological patents of pharmaceutical formulation, APTYS Pharmaceuticals aims to develop an innovative pain treatment in collaboration with UNITHER Pharmaceuticals.<\/p>\n<p>While the withdrawal of dextropropoxyphene in 2010 caused a flaw in the therapeutic pain arsenal in Europe, the use of opioids has significantly increased in recent decades.<\/p>\n<p>Initially, APTYS Pharmaceuticals decided to focus its efforts on the development of a treatment for moderate to severe pain (level II) based on the synergy of two non-opioid analgesics, thus reducing the risks of abuse and opioid dependence. The company has already entered into a strategic partnership with a major player in the pharmaceutical industry in France, UNITHER Pharmaceuticals.<\/p>\n<p>This fundraising will allow APTYS to strengthen its team, and the 2 partners to finalize the development of this new treatment up to the AMM, and then to offer it to a pharmaceutical laboratory under a license agreement or sale.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #008000;\"><strong>APTYS PHARMACEUTICALS<\/strong><\/span><br \/>\n<span style=\"color: #008000;\"><strong>Biop\u00f4le Clermont-Limagne<\/strong><\/span><br \/>\nPhone: 04.73.67.06.70<br \/>\nE-mail :\u00a0<a href=\"mailto:contact@aptys-pharmaceuticals.com\">contact@aptys-pharmaceuticals.com<\/a><br \/>\nWebsite : <a href=\"http:\/\/www.aptys-pharmaceuticals.com\/\">www.aptys-pharmaceuticals.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Founded in 2002 by Fran\u00e7ois Boutignon following the signing of agreements with the Universit\u00e9 d\u2019Auvergne to obtain exploitation rights for technological patents of pharmaceutical formulation, APTYS Pharmaceuticals aims to develop an innovative pain treatment in collaboration with UNITHER Pharmaceuticals. While the withdrawal of dextropropoxyphene in 2010 caused a flaw in the therapeutic pain arsenal in [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1891,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1991","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>APTYS PHARMACEUTICALS, a laboratory specialized in galenical formulation, announces that it has completed a \u20ac 2.1 million fundraiser led by NDLS Conseil from the Meeschaert family office. - Arbios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"APTYS PHARMACEUTICALS, a laboratory specialized in galenical formulation, announces that it has completed a \u20ac 2.1 million fundraiser led by NDLS Conseil from the Meeschaert family office. - Arbios\" \/>\n<meta property=\"og:description\" content=\"Founded in 2002 by Fran\u00e7ois Boutignon following the signing of agreements with the Universit\u00e9 d\u2019Auvergne to obtain exploitation rights for technological patents of pharmaceutical formulation, APTYS Pharmaceuticals aims to develop an innovative pain treatment in collaboration with UNITHER Pharmaceuticals. While the withdrawal of dextropropoxyphene in 2010 caused a flaw in the therapeutic pain arsenal in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/\" \/>\n<meta property=\"og:site_name\" content=\"Arbios\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-21T10:30:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.arbios.org\/wp-content\/uploads\/2017\/01\/AP-LOGO.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"680\" \/>\n\t<meta property=\"og:image:height\" content=\"340\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"arbios\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"arbios\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/\"},\"author\":{\"name\":\"arbios\",\"@id\":\"https:\\\/\\\/www.arbios.org\\\/#\\\/schema\\\/person\\\/d4764a06f595d90cc731f0cbaa14ba7b\"},\"headline\":\"APTYS PHARMACEUTICALS, a laboratory specialized in galenical formulation, announces that it has completed a \u20ac 2.1 million fundraiser led by NDLS Conseil from the Meeschaert family office.\",\"datePublished\":\"2020-01-21T10:30:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/\"},\"wordCount\":204,\"image\":{\"@id\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.arbios.org\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/AP-LOGO.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/\",\"url\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/\",\"name\":\"APTYS PHARMACEUTICALS, a laboratory specialized in galenical formulation, announces that it has completed a \u20ac 2.1 million fundraiser led by NDLS Conseil from the Meeschaert family office. - Arbios\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.arbios.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.arbios.org\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/AP-LOGO.jpg\",\"datePublished\":\"2020-01-21T10:30:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.arbios.org\\\/#\\\/schema\\\/person\\\/d4764a06f595d90cc731f0cbaa14ba7b\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.arbios.org\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/AP-LOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/www.arbios.org\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/AP-LOGO.jpg\",\"width\":680,\"height\":340},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.arbios.org\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"APTYS PHARMACEUTICALS, a laboratory specialized in galenical formulation, announces that it has completed a \u20ac 2.1 million fundraiser led by NDLS Conseil from the Meeschaert family office.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.arbios.org\\\/#website\",\"url\":\"https:\\\/\\\/www.arbios.org\\\/\",\"name\":\"Arbios\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.arbios.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.arbios.org\\\/#\\\/schema\\\/person\\\/d4764a06f595d90cc731f0cbaa14ba7b\",\"name\":\"arbios\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g\",\"caption\":\"arbios\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"APTYS PHARMACEUTICALS, a laboratory specialized in galenical formulation, announces that it has completed a \u20ac 2.1 million fundraiser led by NDLS Conseil from the Meeschaert family office. - Arbios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/","og_locale":"en_US","og_type":"article","og_title":"APTYS PHARMACEUTICALS, a laboratory specialized in galenical formulation, announces that it has completed a \u20ac 2.1 million fundraiser led by NDLS Conseil from the Meeschaert family office. - Arbios","og_description":"Founded in 2002 by Fran\u00e7ois Boutignon following the signing of agreements with the Universit\u00e9 d\u2019Auvergne to obtain exploitation rights for technological patents of pharmaceutical formulation, APTYS Pharmaceuticals aims to develop an innovative pain treatment in collaboration with UNITHER Pharmaceuticals. While the withdrawal of dextropropoxyphene in 2010 caused a flaw in the therapeutic pain arsenal in [&hellip;]","og_url":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/","og_site_name":"Arbios","article_published_time":"2020-01-21T10:30:21+00:00","og_image":[{"width":680,"height":340,"url":"https:\/\/www.arbios.org\/wp-content\/uploads\/2017\/01\/AP-LOGO.jpg","type":"image\/jpeg"}],"author":"arbios","twitter_card":"summary_large_image","twitter_misc":{"Written by":"arbios","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/#article","isPartOf":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/"},"author":{"name":"arbios","@id":"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b"},"headline":"APTYS PHARMACEUTICALS, a laboratory specialized in galenical formulation, announces that it has completed a \u20ac 2.1 million fundraiser led by NDLS Conseil from the Meeschaert family office.","datePublished":"2020-01-21T10:30:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/"},"wordCount":204,"image":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arbios.org\/wp-content\/uploads\/2017\/01\/AP-LOGO.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/","url":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/","name":"APTYS PHARMACEUTICALS, a laboratory specialized in galenical formulation, announces that it has completed a \u20ac 2.1 million fundraiser led by NDLS Conseil from the Meeschaert family office. - Arbios","isPartOf":{"@id":"https:\/\/www.arbios.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/#primaryimage"},"image":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arbios.org\/wp-content\/uploads\/2017\/01\/AP-LOGO.jpg","datePublished":"2020-01-21T10:30:21+00:00","author":{"@id":"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b"},"breadcrumb":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/#primaryimage","url":"https:\/\/www.arbios.org\/wp-content\/uploads\/2017\/01\/AP-LOGO.jpg","contentUrl":"https:\/\/www.arbios.org\/wp-content\/uploads\/2017\/01\/AP-LOGO.jpg","width":680,"height":340},{"@type":"BreadcrumbList","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-a-laboratory-specialized-in-galenical-formulation-announces-that-it-has-completed-a-e-2-1-million-fundraiser-led-by-ndls-conseil-from-the-meeschaert-family-office\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.arbios.org\/en\/"},{"@type":"ListItem","position":2,"name":"APTYS PHARMACEUTICALS, a laboratory specialized in galenical formulation, announces that it has completed a \u20ac 2.1 million fundraiser led by NDLS Conseil from the Meeschaert family office."}]},{"@type":"WebSite","@id":"https:\/\/www.arbios.org\/#website","url":"https:\/\/www.arbios.org\/","name":"Arbios","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arbios.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b","name":"arbios","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g","caption":"arbios"}}]}},"_links":{"self":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts\/1991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/comments?post=1991"}],"version-history":[{"count":1,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts\/1991\/revisions"}],"predecessor-version":[{"id":1992,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts\/1991\/revisions\/1992"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/media\/1891"}],"wp:attachment":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/media?parent=1991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}